Navigation Links
Data Published in The New England Journal of Medicine Support Use of Raxibacumab (ABthrax(TM)) for the Treatment of Inhalation Anthrax
Date:7/9/2009

d Syncria(R) (albiglutide), currently in Phase 3 development as a potential treatment for type 2 diabetes.

For more information about HGS, please visit the Company's web site at www.hgsi.com. Health professionals and patients interested in clinical trials of HGS products may inquire via e-mail to clinical_trials@hgsi.com or by calling HGS at (301) 610-5790, extension 3550.

HGS, Human Genome Sciences, ABthrax, Albuferon, BENLYSTA and LymphoStat-B are trademarks of Human Genome Sciences, Inc.

Safe Harbor Statement

This announcement contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. The forward-looking statements are based on Human Genome Sciences' current intent, belief and expectations. These statements are not guarantees of future performance and are subject to certain risks and uncertainties that are difficult to predict. Actual results may differ materially from these forward-looking statements because of the Company's unproven business model, its dependence on new technologies, the uncertainty and timing of clinical trials, the Company's ability to develop and commercialize products, its dependence on collaborators for services and revenue, its substantial indebtedness and lease obligations, its changing requirements and costs associated with facilities, intense competition, the uncertainty of patent and intellectual property protection, the Company's dependence on key management and key suppliers, the uncertainty of regulation of products, the impact of future alliances or transactions and other risks described in the Company's filings with the Securities and
'/>"/>

SOURCE Human Genome Sciences, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Study Published in Clinical Cancer Research Confirms Potential Of Peregrines Bavituximab Combined With Radiation In Lung Cancer
2. PharmAthene Named as Contractor in $13.9 Million Award Notice Published by the Department of Health and Human Services
3. In response to a New England Journal of Medicine article published yesterday and subsequent media coverage, Eli Lilly and Company issued the following statement:
4. Vasogens Research Published in European Journal of Neuroscience
5. The LANCET Published ENDORSE, the Largest Multinational Study Showing That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE Prophylaxis
6. Newly Published EPA RCRA Method 6800 Supports AIT Technology
7. Pyratine-6(TM) Study Published in Journal of Drugs in Dermatology
8. WHI Findings Published in JAMA Do Not Affect Clinical Guidance for the Appropriate Use of Hormone Therapy
9. Synvista Therapeutics Highlights Newly Published Data Demonstrating the Value of Haptoglobin Genotype Testing In People with Diabetes
10. Complete ANX-530 Safety Data to be Published in the 2008 Proceedings of the American Society of Clinical Oncology
11. Accurate Identification of Tumor Origin Using MicroRNAs is Published by Rosetta Genomics Scientists and Collaborators in Nature Biotechnology

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)..., REYKJAVIK,Iceland,November24/PRNewswire-First...ouncedthatithasreceivednoticefrom,theNasdaqStockMa...pendedasofNovember30,2009andaForm25-NSEwillbefiled...emovedeCODE,scommonstock,fromlistingonNasdaq,unles...cationsPanel.Thecompanyhasfiledsuchanappeal,which,...
(Date:11/24/2009)..., REYKJAVIK,Iceland,November24/PRNewswire-First...ouncedtheapprovalofallofits,"firstday"motionsbythe...ankruptcyCourt").deCODElastweekfiledavoluntarypeti...uptcyCodewiththe,BankruptcyCourt. , Theorders...e,tooperateitsbusinessduringtheChapter11proceeding...
(Date:11/24/2009)..., SHANGHAI,Nov.24/PRNewswire-Asia/--ShanghaiBio...ration(SFDA)hasapprovedthe,investigationalnewdruga...ninnovativeinsulinformulationtotreatdiabetes.ThisI...inicalstudy. , Diabetesisadisordercharacteris...ationsofdiabetesoftenresultinseveremicro-and,macro...
(Date:11/24/2009)..., ,Primaryefficacyendpointhasbeenmetforpatientsw..., QUEBECCITY,Nov.24/PRNewswire-FirstCall/-AEter...),aglobalbiopharmaceuticalcompanyfocusedonendocrin...datafromaPhase2studywithitstargetedcytotoxicpeptid...advancedorrecurrentendometrialcancer.Inapersonaliz...
Breaking Biology Technology:deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 3deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3Biolaxy Secures IND Approval for Oral Insulin 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4
..., March 5 NeoStem, Inc. (Amex: NBS ),which is pi...d long-term,storage of adult stem cells for future...n, Ph.D., NeoStem,s Director of Stem Cell Science ... campus this evening. In,October 2007, NeoStem ann...cell collection centers into Las Vegas, the first ...
...N, N.J., March 5 Novo Nordisk, a,healthcare compa...vement in,diabetes care, today announced plans to ...modate future growth. In the past five years, the ...employees at its U.S.,headquarters., The new buil...oyees and,feature an in-house training facility ca...
...PHIA, March 5 Cellvizio Inc., a leader in in,vivo...live U.S.,demonstration of its Cellvizio(R) GI tec...e Johns Hopkins University School of Medicine,s Ei...a Vida Conference., Cellvizio Inc. is the U.S. su... develops and markets Cellvizio, a fundamentally n...
Other Biology Technology:NeoStem's Denis Rodgerson, Ph.D. to Lecture on Stem Cells and Regenerative Medicine at University of Nevada Las Vegas Campus 2NeoStem's Denis Rodgerson, Ph.D. to Lecture on Stem Cells and Regenerative Medicine at University of Nevada Las Vegas Campus 3Novo Nordisk Expands U.S. Headquarters in New Jersey 2Novo Nordisk Expands U.S. Headquarters in New Jersey 3First Live U.S. Demonstration of Cellvizio GI In Vivo Cellular Imaging Technology to Occur at Johns Hopkins Conference 2
(Date:11/24/2009)...l action of a remarkable class of ring-shaped prot...the Lawrence Berkeley National Laboratory (Berkele...raphy beamline at the Advanced Light Source (ALS)....xpression and replication, and are vital to the su...ous agents, such as the human papillomavirus, whic...
(Date:11/24/2009)...es fish food is a matter of debate. A high-profile...ost 50 percent of their carbon from trees and leav...restrial and aquatic ecosystems. , But new resea...s not likely to be true. Algae provide a much rich... to research published this week in the Proceedin...
(Date:11/23/2009).... The community-associated strain of the deadly s...t to most common antibioticsposes a far greater he...s way into hospitals, according to a study in the ... , The new threat is easily picked up in fitness... increased the overall burden of MRSA within hospi...
Breaking Biology News(10 mins):Atomic-level snapshot catches protein motor in action 2Atomic-level snapshot catches protein motor in action 3Atomic-level snapshot catches protein motor in action 4Fish food fight: Fish don't eat trees after all, says new study 2Fish food fight: Fish don't eat trees after all, says new study 3New study finds MRSA on the rise in hospital outpatients 2Imagenetix Announces Issuance of New U S Patent for the Prevention and Treatment of Periodontal Disease 5973 1Imagenetix Announces Issuance of New U S Patent for the Prevention and Treatment of Periodontal Disease 5973 2WAND Point of Sale Solutions Integrate U are U 28R 29 Fingerprint Biometrics From DigitalPersona for Quick Service Restaurants 10633 1WAND Point of Sale Solutions Integrate U are U 28R 29 Fingerprint Biometrics From DigitalPersona for Quick Service Restaurants 10633 2WAND Point of Sale Solutions Integrate U are U 28R 29 Fingerprint Biometrics From DigitalPersona for Quick Service Restaurants 10633 3BIO key 28R 29 International Exhibiting at AABB TXPO 10629 1BIO key 28R 29 International Exhibiting at AABB TXPO 10629 2
... in German . , Within the last few years the nu...as been increased considerably. A worthwhile effor...sengers. Possibilities for new and safe methods of...on. Before this radiation can be used for this pur...y, so that damage to health caused by radiation ca...
...e mating and nesting practices of a common Austral...sequentially the highest recorded of any vertebra...School of Biological Sciences, has researched the ...ii) for six years and in this latest field trip, d...cies until now. , "Our study revealed that female...
...(NSF) and the U.S. Environmental Protection Agency...or the Environmental Implications of Nanotechnolog...versity, will study how nanomaterials interact wit...l translate this knowledge into risk assessment an...of nanotechnology. , "The new centers will provid...
Other Biology News:Checking people at airports -- with terahertz radiation 2Australian frog species chooses not to put eggs in 1 basket 2NSF and EPA establish 2 centers for environmental implications of nanotechnology 2NSF and EPA establish 2 centers for environmental implications of nanotechnology 3NSF and EPA establish 2 centers for environmental implications of nanotechnology 4
... is commonly used as a fusion partner when express...as been reported to enhance the production and in ...When expressed in a soluble, properly folded form,...ilized glutathione. Gentle elution is achieved wit...
...ly of positioners, offering longer travel while ma... patterns mimic the MX80 family, allowing users to...ets to build multi-axis systems., , Miniature lin...ons to 5 gs , Velocities to 3 m/s , Encoder resolu...
...is from the C-terminal end of the mouse retinoic a...nce extends from amino acids 429 to 448 of RAR*. ...nus): C - P - S - V - S - P - S - S - V - E - N - ...inal cysteine has been added to facilitate conjuga...
...ity ready-to-use cryopreserved neural stem cells (...th and lineage commitment. Just thaw and plate the... in the format you need for a tissue-like mixture ...ytes and oligodendrocytes. Better than neurosphere...
Biology Products: